Cargando…

Molecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review

Peyronie’s disease (PD) is a localized fibrotic lesion of the penis that has adverse effects on men’s health. In this review, we summarized the molecular mechanisms and pharmacotherapies of PD. A literature search was conducted using PubMed and Cochrane Library during 2001–2020. Although no oral or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fuxun, Qin, Feng, Yuan, Jiuhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173627/ https://www.ncbi.nlm.nih.gov/pubmed/34093182 http://dx.doi.org/10.3389/fphar.2021.643641

Ejemplares similares

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
por: Zhang, Fuxun, et al.
Publicado: (2022)

Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
por: Li, Meng, et al.
Publicado: (2022)

Ultrasound on Erect Penis Improves Plaque Identification in Patients With Peyronie’s Disease
por: Liu, Yu, et al.
Publicado: (2019)

Peyronie’s disease: current therapy
por: Pendleton, Clay M., et al.
Publicado: (2013)

AB131. A meta-analysis of extracorporeal shock wave therapy for Peyronie’s disease
por: Gao, Liang, et al.
Publicado: (2015)

Short Sleep Duration and Erectile Dysfunction: A Review of the Literature
por: Zhang, Fuxun, et al.
Publicado: (2022)

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
por: Huang, Mao-Xin, et al.
Publicado: (2021)

Pharmacotherapy for Fibromyalgia
por: Smith, Howard S., et al.
Publicado: (2011)

Current state of affairs of Peyronie’s disease
por: Hellstrom, Wayne J. G., et al.
Publicado: (2016)

Toward a Personalized Pharmacotherapy of Respiratory Diseases
por: Montuschi, Paolo
Publicado: (2010)

Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie’s Disease
por: Mitsui, Yozo, et al.
Publicado: (2023)

Current and emerging treatment options for Peyronie’s disease
por: Gokce, Ahmet, et al.
Publicado: (2013)

Identifying hub genes, key pathways and key immune-related genes in Peyronie’s disease by integrated bioinformatic analysis
por: Cui, Yuanshan, et al.
Publicado: (2022)

Challenges in the Pharmacotherapy of Urogenital Disorders
por: Michel, Martin C.
Publicado: (2010)

Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
por: Husna Ibrahim, Nurul, et al.
Publicado: (2020)

Gender Differences in Cardiovascular Pharmacotherapy—the Example of Hypertension: A Mini Review
por: Kalibala, Jacklean, et al.
Publicado: (2020)

Pharmacotherapy of anxiety disorders: a critical review
por: Koen, Nastassja, et al.
Publicado: (2011)

AB56. Current medical therapy for peyronie’s disease
por: Moon, Ki Hak
Publicado: (2014)

Sleep Related Epilepsy and Pharmacotherapy: An Insight
por: Kumar, Jaya, et al.
Publicado: (2018)

Consistency of recommendations for pharmacotherapy of rheumatoid arthritis
por: Hu, Yue, et al.
Publicado: (2022)

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
por: Wang, Yan-Ni, et al.
Publicado: (2022)

Editorial: The pharmacotherapy of depression—searching for new mechanisms and drug interactions basic and clinical research
por: Stachowicz, Katarzyna, et al.
Publicado: (2022)

Comparative efficacy and acceptability of pharmacotherapies for postpartum depression: A systematic review and network meta-analysis
por: Zhang, Qing, et al.
Publicado: (2022)

The pathophysiology of Peyronie’s disease
por: El-Sakka, Ahmed I., et al.
Publicado: (2013)

Peyronie’s disease: is it genetic or not?
por: Gabrielsen, J. Scott
Publicado: (2020)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
por: Roberts, Bradley, et al.
Publicado: (2023)

Minimally invasive therapies for Peyronie’s disease: the current state of the art
por: Farrell, M. Ryan, et al.
Publicado: (2020)

Pharmacotherapy of Lower Respiratory Tract Infections in Elderly—Focused on Antibiotics
por: Liu, Yang, et al.
Publicado: (2019)

A review of the epidemiology and treatment of Peyronie’s disease
por: Ostrowski, Kevin A, et al.
Publicado: (2016)

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update
por: Soghomonyan, S., et al.
Publicado: (2021)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014)

Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis
por: Panin, Francesca, et al.
Publicado: (2019)

Genetic Evidence Supporting the Causal Role of Homocysteine in Chronic Kidney Disease: A Mendelian Randomization Study
por: Xiong, Yang, et al.
Publicado: (2022)

Pharmacotherapy of mild cognitive impairment
por: Gauthier, Serge
Publicado: (2004)

Peyronie's Disease: Evaluation and Review of Nonsurgical Therapy
por: Abern, Michael R., et al.
Publicado: (2009)

Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis
por: Xu, Yanan, et al.
Publicado: (2023)

Pharmacotherapy of Patients with Mild Persistent Asthma: Strategies and Unresolved Issues
por: Montuschi, Paolo
Publicado: (2011)

Pharmacotherapeutic Patterns and Patients’ Access to Pharmacotherapy for Some Rare Diseases in Bulgaria – A Pilot Comparative Study
por: Kamusheva, Maria, et al.
Publicado: (2021)

Influence of Jamaican Cultural and Religious Beliefs on Adherence to Pharmacotherapy for Non-Communicable Diseases: A Pharmacovigilance Perspective
por: Brown, Robyn, et al.
Publicado: (2022)

Pharmacist‐Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review
por: Xu, Peipei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o66g5udujmgt4pi9gt58mjed74